JMP Securities Downgrades NextCure Inc. (NXTC) to Market Perform, Following Unfavourable Drug Trial Results
Tweet Send to a Friend
JMP Securities analyst Reni J. Benjamin downgraded NextCure Inc. (NASDAQ: NXTC) from Market Outperform to Market Perform (target removed from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
